期刊文献+

厄贝沙坦联合胺碘酮治疗阵发性心房颤动的临床观察 被引量:1

下载PDF
导出
摘要 目的:评价厄贝沙坦与胺碘酮联合治疗阵发性房颤的疗效。方法:将91例阵发房颤患者随机分为胺碘酮组(Ⅰ组,n=45)和胺碘酮+厄贝沙坦组(Ⅱ组,n=46)治疗随访1年。计算两组治疗后3、6、9、12个月的窦性心律维持率和治疗前、治疗后6、12个月的左房前后径。结果:两组治疗前后6、9、12个月,Ⅰ组窦性维持率低于Ⅱ组,两组有显著性差异(P〈0.05)。结论:厄贝沙坦与胺碘酮联合治疗阵发性心房颤动维持窦性心律的疗效优于单用胺碘酮,且能抑制左房扩大。 irbesartan and evaluation purposes amiodarone the paroxysmal atrial fibrillation of treatment, method wrote a : example, patients with atrial fibrillation randomly divided into groups amiodarone( Ⅰ groups, n a and iodine 45 ) amiodarone., sand, groups of seashells ( ii, n a total of 46 ) follow--up treatment of one year. the two groups of treatment 3, 6 and 9, 12 months of the sinuses are sexual beat the rate for treatment and, six or 12 months after he left the house, the two groups before and after treatment : 6, 9, 12 months, the rate of the sinuses are Ⅰ group ii below, two groups of a notable
作者 李卫东
出处 《医学信息(下旬刊)》 2010年第7期80-80,共1页 Medical information
关键词 心房颤动 厄贝沙坦 胺碘酮 Heart vibrated irbesartan amiodarone
  • 相关文献

参考文献8

  • 1Pedersen OD,Bagger H,Kober L,etal.Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.Circulation 1999;100:376-380.
  • 2Goette A,Arndt M,Rocken C,etal.Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in humans.Circulation 2000;101:2678-2681.
  • 3Kumagai K,Nakashima H,Urata H,etal.Effects of angiotensin Ⅱ type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.J Am Coll Cardiol 2003;41:2197-2204.
  • 4Hideko N,Koickiro K,HidenoriU,etal.Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation.Circulation,2000,101:2612-2617.
  • 5Madrid AH,Bueno MG,Rebollo JM,et al.Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomized study.Circulation 2002;106:331-336.
  • 6Pitt B,Segal R,Maytinez F,et al.Randomized trial of losartan versus captopril in patients over 65 with heart failure(evaluation of losartan in the elderly study,ELITE)[J].Lancet,1997;349:747-752.
  • 7Ricardo C,Eva DC,Carmen V,et al.Losartan and its metabolite E3174 modify cardiac delayed rectifier K+ currents[J].Circulation,2000;101:1195-1205.
  • 8杨俊,黄从新,江洪,王腾.厄贝沙坦电生理作用的实验研究[J].第四军医大学学报,2005,26(1):17-21. 被引量:6

二级参考文献1

共引文献5

同被引文献16

  • 1代运国,袁俊强,宋亚辉,李玉杰.胺碘酮联合厄贝沙坦治疗阵发性房颤[J].医药论坛杂志,2007,28(5):101-102. 被引量:2
  • 2Issae T T, Dokainish H, Lakkis N M. Role of inflammation in initiation arid perpetuation of atrial fibrillation : a systematic review of the published data[ J]. J Am CoU Cardiol,2007 ,50( 21 ) :2021-2028.
  • 3Nattel S. New ideas about atrial fibrillation 50 years on [ J ]. Nature ,2002,415 (6868) :219-226.
  • 4Higgins J P T, Green S. Cochrane handbook for systematic reviews of interventions4.2.6 [ updated September 2006 ]. In : The Cochrane Library, Issue 4,2006. Chichester, UK : John Wiley & Sons, Ltd.
  • 5Yin Y, Dalai D, Liu Z,et al. Prospective randomized study comparing amiodarane vs. amiodamne plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation [ J ]. Eur Heart J, 2006,27(15) :1841-1846.
  • 6Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation : mechanisms and implications [ J ]. Circ Arrhythm Electrophysiol,2008,1 ( 1 ) :62-73.
  • 7Onohara N, Nishida M, Inoue R, et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy [ J]. EMBO J, 2006,25 : 5305 -5316.
  • 8廖伟,阳贻红,严章林,廖永玲.厄贝沙坦联合胺碘酮治疗非瓣膜病阵发性心房颤动疗效观察[J].山东医药,2008,48(7):66-67. 被引量:4
  • 9李世光,陈良余,王超,周杨,倪训业,严激.胺碘酮联用缬沙坦治疗阵发性房颤临床疗效观察[J].安徽卫生职业技术学院学报,2008,7(4):50-51. 被引量:5
  • 10曹道俊,慕春言,仝峰,汤日波.厄贝沙坦联合胺碘酮治疗老年阵发性心房颤动的临床观察[J].中南大学学报(医学版),2008,33(9):871-874. 被引量:12

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部